Association of TIMP-2 Rs8179090 Genotypes With Lung Cancer Risk in Taiwan

Wei-Chih Liao1,2, Chien-Wen Huang3, Te-Chun Hsia1,4

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.

Anticancer Research
|November 4, 2021
PubMed
Abstract

Insights

The tissue inhibitor of metalloproteinase-2 (TIMP-2) -418G/C gene variant does not appear to influence lung cancer risk. This genetic variation is unlikely to be a reliable predictor for developing lung cancer.

Area of Science:

  • Genetics and Genomics
  • Cancer Biology
  • Molecular Medicine

Background:

  • The tissue inhibitor of metalloproteinase-2 (TIMP-2) is a key regulator of extracellular matrix (ECM) degradation and remodeling.
  • TIMP-2, alongside matrix metalloproteinases (MMPs), plays a crucial role in maintaining tissue homeostasis.
  • Dysregulation of ECM remodeling is implicated in various diseases, including cancer.

Purpose of the Study:

  • To investigate the association between the TIMP-2 -418G/C single nucleotide polymorphism (SNP) and the risk of developing lung cancer.
  • To determine if specific genotypes of the TIMP-2 -418G/C polymorphism are linked to lung cancer susceptibility.

Main Methods:

  • A case-control study was conducted with 358 lung cancer patients and 716 healthy controls.
  • Genotyping for the TIMP-2 -418G/C (rs8179090) polymorphism was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.

Main Results:

  • No statistically significant differences were observed in the distribution of TIMP-2 -418G/C allele and genotype frequencies between lung cancer patients and healthy controls (p>0.05).
  • The frequencies of heterozygous and homozygous variant genotypes of TIMP-2 -418G/C did not differ significantly between the case and control groups (p>0.05).

Conclusions:

  • The studied TIMP-2 -418G/C genetic variants are unlikely to be associated with lung cancer susceptibility.
  • These specific TIMP-2 gene variants may not serve as effective predictive biomarkers for lung cancer risk.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.1K